PolarityTE to Effectuate 1-for-25 Reverse Stock Split
SALT LAKE CITY, May 16, 2022 /PRNewswire/ — PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today announced that the Company will effectuate a 1-for-25 reverse stock split of the Company’s issued and outstanding common stock, which will be effective under Delaware law at 4:15 p.m. Eastern Time on Monday, May 16, 2022. As of that time, each 25 shares of issued and outstanding common stock and equivalents will be converted into one share of common stock. A new CUSIP number has been assigned to the Company’s common stock as a result of the reverse stock split, which is 731094 207. The Company’s common stock will trade on The Nasdaq Capital Market on a reverse split basis beginning on May 17, 2022.
